Compare GSK plc (GSK) vs LTC Properties Inc (LTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs LTC Properties Inc — how do they compare? GSK plc trades at $52.71 (market cap $101.34B), while LTC Properties Inc trades at $41.08 (market cap $2.05B). The key difference: GSK plc is far larger — about 49.4× LTC Properties Inc's market cap, and LTC Properties Inc pays the higher dividend (5.69%). Which is the better fit depends on your goals.
| GSK | LTC | |
|---|---|---|
Market Cap | $101.34B | $2.05B |
Sector | Health | Real Estate |
52-Week High | $61.18 | $40.36 |
52-Week Low | $36.20 | $33.98 |
Enterprise Value | $121.95B | $2.90B |
Dividend Yield | 3.49% | 5.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
LTC Properties (NYSE: LTC) trades at $40.54, up 1.27% on the day, with a bullish technical signal from moving averages. The healthcare REIT shows strong profitability with a 39.09% net income margin and consistent monthly dividends of $0.19 per share. Recent strategic moves include expanding its SHOP portfolio with $73M and $54M acquisitions in 2026 and enhancing its credit facility to $1.1B, signaling aggressive growth in senior housing.
The outlook is cautiously optimistic. The shift toward SHOP properties aims to materially change the growth profile by year-end 2026, supported by aging demographics. Key risks include recent earnings misses, rising debt levels, and execution of the portfolio transition. Analyst consensus leans Hold (59%), with mixed sentiment between strong fundamentals and near-term operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →
